This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Pyrazinamide
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | <StructureSection load='' size='340' side='right' caption='Caption for this structure' scene='10/1022084/Cv/ | + | <StructureSection load='' size='340' side='right' caption='Caption for this structure' scene='10/1022084/Cv/2'> |
Pyrazinamide is a medication used to treat tuberculosis.<ref name="a2">[https://www.drugs.com/monograph/pyrazinamide.html "Pyrazinamide".] The American Society of Health-System Pharmacists. Archived from the original on 20 December 2016. Retrieved 8 December 2016.</ref> For active tuberculosis, it is often used with rifampicin, isoniazid, and either streptomycin or ethambutol.<ref name="a3">World Health Organization (2009). Stuart MC, Kouimtzi M, Hill SR (eds.). WHO Model Formulary. World Health Organization. pp. 136, 140, 594, 608. hdl:10665/44053. ISBN 978-9241547659.</ref> It is not generally recommended for the treatment of latent tuberculosis.<ref name="a2">[https://www.drugs.com/monograph/pyrazinamide.html "Pyrazinamide".] The American Society of Health-System Pharmacists. Archived from the original on 20 December 2016. Retrieved 8 December 2016.</ref> See also [https://en.wikipedia.org/wiki/Pyrazinamide Pyrazinamide]. | Pyrazinamide is a medication used to treat tuberculosis.<ref name="a2">[https://www.drugs.com/monograph/pyrazinamide.html "Pyrazinamide".] The American Society of Health-System Pharmacists. Archived from the original on 20 December 2016. Retrieved 8 December 2016.</ref> For active tuberculosis, it is often used with rifampicin, isoniazid, and either streptomycin or ethambutol.<ref name="a3">World Health Organization (2009). Stuart MC, Kouimtzi M, Hill SR (eds.). WHO Model Formulary. World Health Organization. pp. 136, 140, 594, 608. hdl:10665/44053. ISBN 978-9241547659.</ref> It is not generally recommended for the treatment of latent tuberculosis.<ref name="a2">[https://www.drugs.com/monograph/pyrazinamide.html "Pyrazinamide".] The American Society of Health-System Pharmacists. Archived from the original on 20 December 2016. Retrieved 8 December 2016.</ref> See also [https://en.wikipedia.org/wiki/Pyrazinamide Pyrazinamide]. | ||
Revision as of 13:23, 1 January 2024
| |||||||||||
References
- ↑ 1.0 1.1 "Pyrazinamide". The American Society of Health-System Pharmacists. Archived from the original on 20 December 2016. Retrieved 8 December 2016.
- ↑ World Health Organization (2009). Stuart MC, Kouimtzi M, Hill SR (eds.). WHO Model Formulary. World Health Organization. pp. 136, 140, 594, 608. hdl:10665/44053. ISBN 978-9241547659.
